Kerr Douglas bought DYN
October 20, 2026 · Form 4 insider transaction
Kerr Douglas bought 12,000 shares of Dyne Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
12,000
Price
$0.00
Total value
N/A
InsiderKerr Douglas
RoleOfficer
SecurityStock option (right to buy)
Transaction codeA: Grant or award
Transaction dateOctober 20, 2026
Filing dateOctober 22, 2026
Shares owned after12,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This option was granted on October 20, 2026. The shares underlying the option are scheduled to vest over four years in equal monthly installments through October 20, 2030.